The fifth training programme would be held under the aegis of WHO, IPC and the ministry of health and family welfare, Central government.
The meeting would focus over various aspects of pharmacovigilance, including quality and completeness of reports, causality assessment. Drugs of current interest in pharmacovigilance would be emphasized over. Measures to be taken for increasing the reporting of adverse drug reactions would be discussed.
Further, the meeting would provide a platform to participants for exchanging their experiences and ideas for the success of the pharmacovigilance programme.